-
Mashup Score: 2Researchers pioneer technology that leads successful clinical trial to treat dry eye disease - 2 year(s) ago
A team of investigators at the Texas Tech University Health Sciences Center have developed a technology derived from corneal epithelial stem cells to improve outcomes for DED patients.
Source: Ophthalmology TimesCategories: Latest Headlines, OphthalmologyTweet
-
Mashup Score: 4Mitomycin C increases corneal haze after corneal crosslinking - 2 year(s) ago
Shady Awwad, MD, discusses how the application of mitomycin C after corneal crosslinking does not prevent development of corneal haze after the procedure and actually contributes to development of more corneal haze.
Source: Ophthalmology TimesCategories: Latest Headlines, OphthalmologyTweet-
Application of mitomycin C after #corneal crosslinking actually contributes to the development of more corneal haze, according to new research presented at #AAO2021. Read more: https://t.co/Om9SDlUzld #Ophthalmology #AAO #cornea @AUBMC_Official @aao_ophth https://t.co/L0wTSkX5au
-
-
Mashup Score: 10YO Need to Know: 5 Pearls for Managing Corneal Ulcers - 2 year(s) ago
If you’re faced with treating a corneal ulcer, you’ll need to do it quickly and with an understanding of how it heals and how to prevent recurrence. Here are some tips to managing keratitis.
Categories: Latest Headlines, OphthalmologyTweet-
Faced with treating a #corneal #ulcer? These tips will help you better manage #keratitis with an eye on healing and preventing recurrence #YOInfo #ophthalmology https://t.co/jslWuD73mp
-
-
Mashup Score: 2
Results from Aurion Biotech’s IOTA trial reveals that a corneal endothelial cell therapy showed improvements in visual acuity and central corneal thickness, according to a team of Japanese investigators.
Source: Ophthalmology TimesCategories: Latest Headlines, OphthalmologyTweet-
Landmark treatment: #CellTherapy advances options for #corneal endothelial disease More: https://t.co/N15RvpnJDV #Ophthalmology #Cornea @AurionBiotech https://t.co/QkhWn8zod2
-
-
Mashup Score: 1
The study evaluates three separate cases, each which experiences irreversible changes in their corneal structure caused by challenges in getting timely treatment due to various reasons, including insurance, lost to follow up, and the coronavirus pandemic.
Source: Ophthalmology TimesCategories: Latest Headlines, OphthalmologyTweet-
(VIDEO) Study: #Keratoconus patients experience challenges in getting timely #corneal #crosslinking that has led to permanent changes in their corneal structure Watch here: https://t.co/33xrGCQGik #Ophthalmology #Cornea #OphthoTwitter #ARVO2022 https://t.co/Bx6gRCsss3
-
-
Mashup Score: 2Wolters Kluwer Health - 2 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable…
Source: lww.comCategories: Latest Headlines, OphthalmologyTweet-
In this case report in our sister journal #JCRO, Theo Seiler MD et al discuss three cases of atypical sterile opacifications during the early-postoperative phase after #corneal crosslinking. Read more: https://t.co/lLF3qvh9ar #ophthalmology #ophthalmologist #eyesurgery https://t.co/QboOBcCyPa
-
-
Mashup Score: 1The effects of corneal cross linking on preventing and treating progressive keratoconus - 2 year(s) ago
Philip Dockery, MD, MPH, discusses his paper “Corneal cross linking for progressive keratoconus, a retrospective analysis of 515 consecutive eyes,” with Ophthalmology Times’ David Hutton.
Source: Ophthalmology TimesCategories: Latest Headlines, OphthalmologyTweet-
(VIDEO) The effects of #corneal cross linking on preventing and treating progressive #keratoconus. WATCH here: https://t.co/zwg5e6mknp #Ophthalmology #ASCRS2022 #Clinical #Cornea #ASCRS22 https://t.co/dd7iU1kFtU
-
-
Mashup Score: 1Researchers pioneer technology that leads successful clinical trial to treat dry eye disease - 2 year(s) ago
A team of investigators at the Texas Tech University Health Sciences Center have developed a technology derived from corneal epithelial stem cells to improve outcomes for DED patients.
Source: Ophthalmology TimesCategories: Latest Headlines, OphthalmologyTweet-
Investigators @TTUHSC have developed a technology derived from #corneal epithelial stem cells to improve outcomes for #DryEyeDisease patients Learn more: https://t.co/n6yOXQPYTZ #Ophthalmology #Cornea #DryEye #DED https://t.co/NutYrjeQFF
-
-
Mashup Score: 0Mitomycin C increases corneal haze after corneal crosslinking - 2 year(s) ago
Shady Awwad, MD, discusses how the application of mitomycin C after corneal crosslinking does not prevent development of corneal haze after the procedure and actually contributes to development of more corneal haze.
Source: Ophthalmology TimesCategories: Latest Headlines, OphthalmologyTweet-
Application of mitomycin C after #corneal crosslinking actually contributes to the development of more corneal haze, according to new research presented at #AAO2021. Read more: https://t.co/Bow6WFJ2tB #Ophthalmology #AAO #cornea @AUBMC_Official @aao_ophth https://t.co/Xc4HjIzXNK
-
-
Mashup Score: 2
Results from Aurion Biotech’s IOTA trial reveals that a corneal endothelial cell therapy showed improvements in visual acuity and central corneal thickness, according to a team of Japanese investigators.
Source: Ophthalmology TimesCategories: Latest Headlines, OphthalmologyTweet-
Landmark treatment: #CellTherapy advances options for #corneal endothelial disease More here: https://t.co/nQ9RoQ9Mc5 #Ophthalmology #Cornea @AurionBiotech https://t.co/Nri8SEjqBG
-
Investigators @TTUHSC have developed a technology derived from #corneal epithelial stem cells to improve outcomes for #DryEyeDisease patients Learn more: https://t.co/30qD47Y20n #Ophthalmology #Cornea #DryEye #DED https://t.co/oio5ClODgk